Sign In
Buy ISEE
$39.95
+0 (+0%)
At Close: Oct 09, 2023
Novavax (NVAX) Stock Up YTD on COVID-19 Vaccine Potential
03:25pm, Monday, 29'th Nov 2021 Zacks Investment Research
Novavax (NVAX) is likely to generate huge revenues as the company has started filing approvals for emergency use of its COVID-19 vaccine in multiple nations.
Takeda (TAK) CMV Infection Drug Livtencity Gets FDA Approval
02:08pm, Thursday, 25'th Nov 2021 Zacks Investment Research
The FDA grants approval to the new drug application seeking approval for Takeda's (TAK) maribavir for treating post-transplant cytomegalovirus infection.
Amryt (AMYT) Skin Disorder NDA Review Gets 3 Months Extension
03:31pm, Wednesday, 24'th Nov 2021 Zacks Investment Research
Amryt (AMYT) is seeking approval for Oleogel-S10 for treating epidermolysis bullosa, a rare genetic skin disorder, in the United States and Europe. The FDA extends the review period for the drug's NDA
BioMarin's (BMRN) Dwarfism Drug Gets FDA's Nod, Stock Up
04:23pm, Monday, 22'nd Nov 2021 Zacks Investment Research
Biomarin Pharmaceuticals's (BMRN) Voxzogo is the first medicine in the United States to be approved to treat achondroplasia, the most common form of dwarfism.
Perceptive Advisors Llc Buys PROCEPT BioRobotics Corp, Icosavax Inc, IVERIC bio Inc, Sells ...
12:38am, Wednesday, 17'th Nov 2021 GuruFocus
Related Stocks: ISEE , KOD , VRDN , INBX , ATXS , XENE , PRCT , ICVX , SLGC , HLTH , SMFR , IMRX , KDMN , MDT , DRNA , NARI , EXAS , XLRN ,
Lion Point Capital, LP Buys IVERIC bio Inc, ReNew Energy Global PLC, TG Therapeutics Inc, Sells ...
06:38pm, Tuesday, 16'th Nov 2021 GuruFocus
Related Stocks: TGTX , ISEE , RNW , ATRA , IMRA , MCRB , ORGN , CNP , EXTR , CSIQ ,
Commodore Capital Lp Buys Dicerna Pharmaceuticals Inc, IVERIC bio Inc, Merus NV, Sells , ...
03:38pm, Tuesday, 16'th Nov 2021 GuruFocus
Related Stocks: ISEE , ACRS , VRDN , KURA , PTGX , VTGN , DRNA , MRUS , TNYA , IOVA , RVMD , CNST , MGNX , EPIX , MRSN , MCRB ,
IVERIC bio, Inc. (ISEE) CEO Glenn Sblendorio on Q3 2021 Results - Earnings Call Transcript
01:49pm, Tuesday, 09'th Nov 2021
IVERIC bio, Inc. (ISEE) CEO Glenn Sblendorio on Q3 2021 Results - Earnings Call Transcript
Apellis' Loss Is Iveric Bio's Gain In Lucrative Eye Disease Field
03:00pm, Thursday, 16'th Sep 2021
Iveric Bio is developing Zimura - indicated for Geographic Atrophy - an eye disease that often leads to blindness.
ISEE Stock: Why It Significantly Increased Yesterday
08:01pm, Saturday, 11'th Sep 2021
The stock price of IVERIC bio Inc (NASDAQ: ISEE) increased 62.49% yesterday. This is why it happened.
Iveric Bio to Present at the H.C. Wainwright 23rd Annual Global Investment Conference
04:05pm, Friday, 10'th Sep 2021
NEW YORK--(BUSINESS WIRE)--Iveric announced that Pravin Dugel, M.D., President, will present an overview of the Company at the 2021 H.C. Wainwright Global Investment Conference.
Here's Why Iveric Bio Stock Is Rocketing Higher Today
11:39am, Friday, 10'th Sep 2021
Mixed results from Apellis Pharmaceuticals are good news for Iveric Bio's geographic atrophy program.
ISEE Stock: Why Rival Eye Drug Developer's Disappointment Is a Boon to IVERIC bio
10:58am, Friday, 10'th Sep 2021
IVERIC bio (ISEE) stock is rocketing higher on Friday and there's a couple of catalysts behind the shares' positive movement today. The post ISEE Stock: Why Rival Eye Drug Developer's Disappointment I
Why IVERIC Bio Shares Are Soaring Today
10:40am, Friday, 10'th Sep 2021
IVERIC Bio Inc (NASDAQ: ISEE) is trading significantly higher Friday after Apellis Pharmaceuticals Inc (NASDAQ: APLS) reported results from its Phase 3 DERBY and OAKS studies in geographic atrophy. A
Why Are Iveric Bio Shares Surging In Premarket Friday?
07:28am, Friday, 10'th Sep 2021
Iveric Bio Inc (NASDAQ:ISEE) stock is trading almost 50% higher as the investors are cheering Stifel's initiated coverage on Iveric Bio with a Buy rating and a price target of $22.00. Analyst Anna
